MA25009A1 - Procede de preparation de composes derives de la piperidine pour la preparation de compositions antibacteriennes - Google Patents
Procede de preparation de composes derives de la piperidine pour la preparation de compositions antibacteriennesInfo
- Publication number
- MA25009A1 MA25009A1 MA25816A MA25816A MA25009A1 MA 25009 A1 MA25009 A1 MA 25009A1 MA 25816 A MA25816 A MA 25816A MA 25816 A MA25816 A MA 25816A MA 25009 A1 MA25009 A1 MA 25009A1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- piperidine
- derived compounds
- antibacterial compositions
- antibacterial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
PROCÉDÉ DE PRÉPARATION DE DÉRIVÉS DE LA PIPÉRIDINE ET DE DÉRIVÉS PHARMACEURTIQUES DE CEUX-CI, UTILES DANS LES PROCÉDURES DE TRAITEMENT D'INFECTIONS BACTÉRIENNES CHEZLES MAMMIFÈRES, EN PARTICULIER CHEZ L'HOMME.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9822440.5A GB9822440D0 (en) | 1998-10-14 | 1998-10-14 | Medicaments |
Publications (1)
Publication Number | Publication Date |
---|---|
MA25009A1 true MA25009A1 (fr) | 2000-07-01 |
Family
ID=10840577
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA25816A MA25009A1 (fr) | 1998-10-14 | 1999-10-12 | Procede de preparation de composes derives de la piperidine pour la preparation de compositions antibacteriennes |
Country Status (11)
Country | Link |
---|---|
US (1) | US6602882B1 (fr) |
EP (1) | EP1121355B1 (fr) |
JP (1) | JP2002527434A (fr) |
AT (1) | ATE312831T1 (fr) |
AU (1) | AU6339599A (fr) |
DE (1) | DE69928952T2 (fr) |
ES (1) | ES2255306T3 (fr) |
GB (1) | GB9822440D0 (fr) |
MA (1) | MA25009A1 (fr) |
PE (1) | PE20001112A1 (fr) |
WO (1) | WO2000021952A1 (fr) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TR200001435T2 (tr) | 1997-09-15 | 2000-08-21 | The Procter & Gamble Company | Antimikrobiyal kuinolonlar, bunların bileşimleri ve kullanımları |
GB9822450D0 (en) * | 1998-10-14 | 1998-12-09 | Smithkline Beecham Plc | Medicaments |
GB9914486D0 (en) | 1999-06-21 | 1999-08-18 | Smithkline Beecham Plc | Medicaments |
GB9917408D0 (en) | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
GB9917406D0 (en) * | 1999-07-23 | 1999-09-22 | Smithkline Beecham Plc | Compounds |
SE9902987D0 (sv) | 1999-08-24 | 1999-08-24 | Astra Pharma Prod | Novel compounds |
US6803369B1 (en) | 2000-07-25 | 2004-10-12 | Smithkline Beecham Corporation | Compounds and methods for the treatment of neoplastic disease |
PL366335A1 (en) | 2000-07-26 | 2005-01-24 | Smithkline Beecham P.L.C. | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
DE60119939T2 (de) * | 2000-09-21 | 2006-11-30 | Smithkline Beecham P.L.C., Brentford | Chinolinderivate als antibakterielle mittel |
GB0031088D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
GB0031086D0 (en) * | 2000-12-20 | 2001-01-31 | Smithkline Beecham Plc | Medicaments |
GB0101577D0 (en) * | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
GB0104050D0 (en) | 2001-02-19 | 2001-04-04 | Astrazeneca Ab | Chemical compounds |
GB0107228D0 (en) | 2001-03-22 | 2001-05-16 | Astrazeneca Ab | Chemical compounds |
GB0112836D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0112834D0 (en) * | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
GB0118238D0 (en) * | 2001-07-26 | 2001-09-19 | Smithkline Beecham Plc | Medicaments |
WO2003037259A2 (fr) * | 2001-10-30 | 2003-05-08 | The General Hospital Corporation | Methodes de prevention ou de traitement d'infections bacteriennes ou mycosiques |
SE0103818D0 (sv) | 2001-11-15 | 2001-11-15 | Astrazeneca Ab | Chemical compounds |
EP1470131A2 (fr) * | 2002-01-29 | 2004-10-27 | Glaxo Group Limited | Composes aminopiperidine, leur procede de preparation et compositions pharmaceutiques les contenant |
US7312212B2 (en) * | 2002-01-29 | 2007-12-25 | Glaxo Group Limited | Aminopiperidine derivatives |
TW200409637A (en) | 2002-06-26 | 2004-06-16 | Glaxo Group Ltd | Compounds |
TW200406413A (en) * | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
US6900224B2 (en) | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
EP1560488B1 (fr) | 2002-11-05 | 2010-09-01 | Glaxo Group Limited | Agents antibacteriens |
ES2340484T3 (es) * | 2002-11-05 | 2010-06-04 | Glaxo Group Limited | Agentes antibacterianos. |
EP1567520B1 (fr) | 2002-12-04 | 2008-10-15 | Glaxo Group Limited | Quinoleines et derives nitrogenes de ces composes ainsi que leur utilisation en tant qu'agents antibacteriens |
TW200427688A (en) * | 2002-12-18 | 2004-12-16 | Glaxo Group Ltd | Antibacterial agents |
WO2004078749A1 (fr) * | 2003-03-06 | 2004-09-16 | Glaxo Group Limited | Derives d'uree heterocycliques pour le traitement de la douleur |
WO2004078744A2 (fr) * | 2003-03-07 | 2004-09-16 | Glaxo Group Limited | Derives d'uree |
GB0305426D0 (en) * | 2003-03-08 | 2003-04-16 | Glaxo Group Ltd | Novel compounds |
FR2867472B1 (fr) * | 2004-03-12 | 2008-07-18 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
EP1773831A1 (fr) * | 2004-07-08 | 2007-04-18 | Glaxo Group Limited | Agents antibacteriens |
WO2006081182A2 (fr) | 2005-01-25 | 2006-08-03 | Glaxo Group Limited | Agents antibacteriens |
JP2008528604A (ja) | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | 抗菌剤 |
US7605169B2 (en) * | 2005-01-25 | 2009-10-20 | Glaxo Group Limited | Antibacterial agents |
EP1845995A4 (fr) | 2005-01-25 | 2010-03-03 | Glaxo Group Ltd | Agents antibacteriens |
JP2008528586A (ja) * | 2005-01-25 | 2008-07-31 | グラクソ グループ リミテッド | 抗菌剤 |
US7842810B2 (en) | 2005-03-31 | 2010-11-30 | Janssen Pharmaceutica, Nv | Bicyclic pyrazole compounds as antibacterial agents |
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
ES2376488T3 (es) | 2006-01-26 | 2012-03-14 | Actelion Pharmaceuticals Ltd. | Antibióticos de tetrahidropirano. |
KR20110082635A (ko) | 2006-03-28 | 2011-07-19 | 워너 칠콧 컴퍼니 엘엘씨 | 퀴놀론 중간체를 제조하기 위한 커플링 방법 |
JP5097967B2 (ja) | 2006-03-28 | 2012-12-12 | タイゲン バイオテクノロジー カンパニー,リミテッド | リンゴ酸塩類、及び(3s,5s)−7−[3−アミノ−5−メチルーピペリジニル]−1−シクロプロピル−1,4−ジヒドロ−8−メトキシ−4−オキソ−3−キノリンカルボン酸の多形体類 |
CN101679357A (zh) * | 2007-05-09 | 2010-03-24 | 辉瑞大药厂 | 取代的杂环衍生物及其组合物和作为抗菌剂的药物用途 |
EP2332939A1 (fr) | 2009-11-26 | 2011-06-15 | Æterna Zentaris GmbH | Nouveaux dérivés de naphtyridine et l'utilisation associée en tant qu'inhibiteurs de kinase |
EP3927703B1 (fr) | 2019-02-19 | 2023-04-05 | Univerza V Ljubljani | Antibactériens à base de fragments monocycliques couplés à un échafaudage de naphtyridine aminopipéridine |
KR20220087497A (ko) | 2019-10-18 | 2022-06-24 | 더 리전츠 오브 더 유니버시티 오브 캘리포니아 | 병원성 혈관을 표적화하기 위한 화합물 및 방법 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4418299Y1 (fr) | 1965-01-16 | 1969-08-07 | ||
US4472404A (en) * | 1982-08-16 | 1984-09-18 | The Dow Chemical Company | 8-Quinolinyl carbamates and their use as urinary tract antimicrobials |
EP0387510A1 (fr) * | 1989-02-10 | 1990-09-19 | Bayer Ag | Dérivés de 8-carbamoyloxy-quinoléine, procédé pour leur préparation et leur utilisation comme pesticides |
JPH0495071A (ja) * | 1990-08-10 | 1992-03-27 | Kyorin Pharmaceut Co Ltd | カルバミン酸誘導体 |
JP3169188B2 (ja) * | 1991-01-31 | 2001-05-21 | 杏林製薬株式会社 | カルバミン酸誘導体及びその製造方法 |
WO1994014801A1 (fr) | 1992-12-29 | 1994-07-07 | Smithkline Beecham Plc | Derives heterocycliques de l'uree antagonistes de 5ht2c et 5h¿2b? |
US5849757A (en) * | 1995-02-02 | 1998-12-15 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivatives substituted by a bicyclic amino group as antibacterials |
DE69633196D1 (de) | 1995-10-16 | 2004-09-23 | Fujisawa Pharmaceutical Co | Heterocyclische verbindungen als h+-atpasen |
JP3933244B2 (ja) | 1997-04-04 | 2007-06-20 | 株式会社資生堂 | アルキレンジアミン誘導体及び抗潰瘍剤、抗菌剤 |
DE69908555T2 (de) * | 1998-01-26 | 2004-05-06 | Smithkline Beecham P.L.C., Brentford | Chinolinderivate als antibakterielles arzneimittel |
FR2798656B1 (fr) | 1999-09-17 | 2004-12-17 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent |
-
1998
- 1998-10-14 GB GBGB9822440.5A patent/GB9822440D0/en not_active Ceased
-
1999
- 1999-10-11 US US09/807,341 patent/US6602882B1/en not_active Expired - Fee Related
- 1999-10-11 AT AT99950730T patent/ATE312831T1/de not_active IP Right Cessation
- 1999-10-11 AU AU63395/99A patent/AU6339599A/en not_active Abandoned
- 1999-10-11 DE DE69928952T patent/DE69928952T2/de not_active Expired - Fee Related
- 1999-10-11 EP EP99950730A patent/EP1121355B1/fr not_active Expired - Lifetime
- 1999-10-11 ES ES99950730T patent/ES2255306T3/es not_active Expired - Lifetime
- 1999-10-11 WO PCT/EP1999/007766 patent/WO2000021952A1/fr active IP Right Grant
- 1999-10-11 JP JP2000575858A patent/JP2002527434A/ja active Pending
- 1999-10-12 MA MA25816A patent/MA25009A1/fr unknown
- 1999-10-12 PE PE1999001028A patent/PE20001112A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69928952T2 (de) | 2007-01-11 |
PE20001112A1 (es) | 2000-10-14 |
WO2000021952A1 (fr) | 2000-04-20 |
AU6339599A (en) | 2000-05-01 |
JP2002527434A (ja) | 2002-08-27 |
US6602882B1 (en) | 2003-08-05 |
GB9822440D0 (en) | 1998-12-09 |
ATE312831T1 (de) | 2005-12-15 |
EP1121355B1 (fr) | 2005-12-14 |
DE69928952D1 (de) | 2006-01-19 |
ES2255306T3 (es) | 2006-06-16 |
EP1121355A1 (fr) | 2001-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA25009A1 (fr) | Procede de preparation de composes derives de la piperidine pour la preparation de compositions antibacteriennes | |
DE60123276D1 (de) | Piperazinderivate zur behandlung bakterieller infektionen | |
AU2002328972A1 (en) | Piperidine derivatives as antibacterial agents | |
AU6825300A (en) | Compounds | |
WO2003064431A3 (fr) | Composes aminopiperidine, leur procede de preparation et compositions pharmaceutiques les contenant | |
MA26424A1 (fr) | Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant. | |
TWI232219B (en) | Compounds containing cyclohexane group, process for preparing them and pharmaceutical composition containing them | |
MA25493A1 (fr) | Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux. | |
IL165715A0 (en) | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
BG103947A (en) | Derivatives of 9-oxymerythromycin | |
MA23490A1 (fr) | Derives de lipopeptide, procede pour leur preparation, composition les contenant et leur utilisation . | |
RU93004457A (ru) | 1-карба-(1-детиа)-цефемы и промежуточные продукты для их получения | |
MY131300A (en) | Antibacterial agents | |
FR2791059B1 (fr) | Proteine modifiee, procede de preparation de celle-ci et compositions pour une application externe contenant la proteine modifiee | |
EE200000587A (et) | Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis | |
BR0002577A (pt) | Suspensões orais de trovafloxacina | |
WO2000010998A3 (fr) | Antibiotique au pyridone a profil d'innocuite ameliore | |
MA26606A1 (fr) | Derives de 5-desoxycytidine, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation. | |
MA26823A1 (fr) | Nouveaux derives de pyrimidine-2,4,6-trione, procede pour leur fabrication et agents pharmaceutiques contenant ces composes. | |
EE200100253A (et) | 2,4-diasendatud triasiiniderivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod, kombinatsioon ning saadus | |
DE60003074D1 (de) | Fusidinsäure-derivate | |
NO20042711L (no) | Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum | |
ECSP993176A (es) | Nuevos compuestos y composiciones antibacterianas | |
PT874863E (pt) | Derivados 3-desoxi-3-descladinose de eritromicinasa e b |